Results 221 to 230 of about 200,281 (336)

[Efficacy and safety of daratumumab in the treatment of advanced light chain amyloidosis].

, 2022
Kai Shen, Huilei Miao, Yajuan Gao, Xinxin Cao, Daobin Zhou, Wei Su, Jing Li   +6 more
openalex   +2 more sources

The incidence of serious complications after selective laser trabeculoplasty

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT). Methods All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018.
Eeva S. Ojanen, Joni A. Turunen, Mika Harju   +2 more
wiley   +1 more source

Co-Existing ATTR Amyloidosis and Coronary Artery Disease: A Risky Combination. [PDF]

Clin Case Rep
Planchat A, Guijarro D, Musayeb Y, Giannakopoulos G, Giraud R, Poku NK, Py DA, Noble S.   +7 more
europepmc   +1 more source

Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis

Journal of the American College of Cardiology, 2020
C. Nitsche, P. Scully, Kush P. Patel, A. Kammerlander, M. Koschutnik, C. Doña, T. Wollenweber, N. Ahmed, G. Thornton, A. Kelion, N. Sabharwal, J. Newton, M. Ozkor, S. Kennon, M. Mullen, G. Lloyd, M. Fontana, P. Hawkins, F. Pugliese, L. Menezes, J. Moon, J. Mascherbauer, T. Treibel   +22 more
semanticscholar   +1 more source

Mapping VEXAS‐associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population

British Journal of Haematology, EarlyView.
VEXAS syndrome is a late‐onset inflammatory disorder with rheumatological and haematological features. Epidemiological studies of VEXAS syndrome so far have been limited. Analysis of various UK cohorts estimates the incidence of VEXAS to be 1.51/100 000, or 171 new cases in the population of men over the age of 50 who are being investigated for myeloid
Ana Martinez Rodriguez, Leon Chang, Dorota Rowczenio, Alexandra Smith, Ebun Omoyinmi, James A. Poulter, Andrew McGregor, Sebastian Francis, Roochi Trikha, Adam Al‐Hakim, Kar Lok Kong, David G. Kent, Helen Lachmann, Austin Kulasekararaj, Catherine Cargo, Sinisa Savic   +15 more
wiley   +1 more source

Primary Amyloidosis Unmasked by Gastric Biopsy: A Case Report. [PDF]

Clin Med Insights Case Rep
Youssef T, Zodeh K, Hoyek K, Bedran A, Bayeh A, Attieh P, Karam K, Othman M.   +7 more
europepmc   +1 more source

Fibrinogen A α-chain amyloidosis associated with a rare frameshift pathogenic variant p.Arg547GlyfsTer21

, 2022
Masayoshi Tasaki, Toshiya Nomura, Koichi Uchiyama, Yohei Misumi, Keiichi Nakahara, Yuzo Oyama, Noriko Uesugi, Mitsuharu Ueda   +7 more
openalex   +1 more source

Primary myelofibrosis with increased haemoglobin concentration at presentation

British Journal of Haematology, EarlyView.
Subjects with primary myelofibrosis and elevated haemoglobin levels at diagnosis tend to have longer survival rates (OS) and blast transformation‐free survival (BTFS) than those with normal or reduced haemoglobin levels. Summary One hundred of 963 consecutive registrants with primary myelofibrosis (PMF) in the Pavia‐CSM database had haemoglobin ...
Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Annalisa De Silvestri, Robert Peter Gale, Vittorio Rosti   +8 more
wiley   +1 more source

Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant

Kidney International Reports, 2017
Tatiana Prokaeva, Harun Akar, Brian Spencer, Andrea Havasi, Haili Cui, Carl J. O’Hara, Olga Gursky, John Leszyk, Martin Steffen, Sabrina Browning, Allison Rosenberg, Lawreen H. Connors   +11 more
doaj   +1 more source

Rare Oral Manifestations of Systemic Amyloidosis: A Case Report. [PDF]

Case Rep Hematol
Barazanji S, Herrera JG, Garming-Legert K.   +2 more
europepmc   +1 more source